Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Baroda BNP Paribas ESG Best-in-Class Strategy Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataBaroda BNP
NAV₹40.2296₹10.9097
NAV date20 Nov 202620 Nov 2026
History10.9 years9 months
Expense ratio1.1%1.2%
Stars★★★★★Not rated
Growth Score67.50—

Returns

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
1 month+9.87%+9.70%
3 months+1.12%+1.66%
6 months+7.63%+6.67%
YTD+13.73%—
1 year+11.82%—
3 years (CAGR)+18.74%—
5 years (CAGR)+16.00%—
10 years (CAGR)+15.95%—
Since launch+13.58%+8.90%

Risk

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Volatility15.7%—
Downside volatility10.0%—
Sharpe0.78—
Sortino1.23—
Calmar1.12—
Return / risk1.19—
Deepest fall−19.84%−10.15%
Days to recover37543
Below its high+0.00%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Alpha−2.76%—
Beta1.00—
R²90.2%—
Up capture91.7%—
Down capture101.4%—
Tracking error4.9%—
Information ratio−0.57—
Treynor0.11—

Consistency

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Best 1-year+76.35%—
Middle 1-year+8.85%—
Worst 1-year−17.32%—
1-year periods with a loss29.0%—
Middle 3-year+21.13%—
Positive months63.9%—
Best day+3.34%+2.40%
Worst day−3.09%−1.90%
Worst 5% day−1.35%−1.11%
Positive days55.4%54.3%
NAVs a year247176

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
5-year XIRR+18.07%—
5-year value₹9,50,065—
3-year XIRR+13.31%—
1-year XIRR+18.41%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth